Keapstone Therapeutics Limited is an active company incorporated on 1 February 2017 with the registered office located in Sheffield, South Yorkshire. Keapstone Therapeutics Limited was registered 8 years ago.
Keapstone Therapeutics is a biotech company that develops drugs targeting the Nrf2 signaling pathway for neuroprotection in conditions such as Parkinson's disease and motor neuron disease.
Financials
Net Assets, Total Assets & Total Liabilities (2018–2024)